Glucagon: Its effects on the hepatic arterial and portal venous beds in dogs
Tóm tắt
The effects of intravenous, intra-arterial and intraportal administration of glucagon on hepatic artery and portal vein flows were studied in anaesthetized dogs. Intravenous administration of glucagon (10 μg/kg) increased hepatic arterial and portal venous flows by 155% and 176% of the control value respectively. Intraarterial injection of glucagon increased hepatic artery flow and decreased its resistance. The hepatic arterial effect of glucagon was dose-dependent and was not abolished after β-adrenoceptor blockade by propranolol 1 mg/kg i.v., or after denervation. Intraportal injection of glucagon had no direct immediate (<15 sec) effect on portal venous flow or pressure. This was followed by an increase in portal vein flow and pressure reaching maximal response within 3–5 min. This late effect was most likely the result of the mesenteric vasodilator action of glucagon. It is concluded that glucagon posses a direct dilator action on the hepatic artery, and indirectly influences the portal venous circulation. Glucagon may have a physiological role in the hepatic vascular bed.
Tài liệu tham khảo
Bernard, S., Duchesne, G., Herman, B.: Use of glucagon by continuous perfusion in treatment of shock. Presse méd.79, 267–270 (1971)
Brogan, E., Kozonis, M. C., Overy, D. C.: Glucagon therapy in heart failure. LancetI, 482–484 1969
Diamon, G., Forrester, J., Dauzig, R., Parmley, W., Swan, H. J.: Hemodynamic effects of glucagon during acute myocardial infarction with left ventricular failure in man. Brit. Heart J.33, 290–295 (1971)
Farah, A., Tuttle, R.: Studies on the pharmacology of glucagon. J. Pharmacol. exp. Ther.129, 49–55 (1960)
Geumei, A., Mahfouz, M.: The presence of β-adrenergic receptors in the hepatic vasculature. Brit. J. Pharmacol.32, 466–472 (1968)
Haddy, F.: Pathophysiology and therapy of the shock of myocardial infarction. Ann. intern. Med.73, 809–827 (1970)
Henneman, D. H., Shoemaker, W. C.: Effect of glucagon and epinephrine on regional metabolism of glucose, pyruvate, lactate and citrate in normal conscious dogs. Endocrinology68, 889–898 (1961)
Hill, A. B.: Principles of medical statistics, 8th edit., pp. 143–151. Oxford: University Press 1966
Kibler, R. F., Taylor, W. J., Myers, J. D.: The effect of glucagon on net splanchnic balances of glucose, amino-acid nitrogen, urea, ketones and oxygen in man. J. clin. Invest.43, 904–915 (1964).
Kock, N. G., Tibblin, S., Schenk, W. G.: Hemodynamic responses to glucagon: An experimental study of central, visceral and peripheral effects. Ann. Surg.171, 373–379 (1970)
Linhart, J. W., Barold, S. S., Cohen, L. S., Hilder, F. J., Samet, P.: Cardiovascular effects of glucagon in man. Amer. J. Cardiol.22, 706–710 (1968)
Lucchesi, B. R., Stutz, D. R., Winfield, R. A.: Glucagon. Its enhancement of atrioventricular nodal pacemaker activity and failure to increase ventricular automaticity in dogs. Circulat. Res.25, 183–190 (1969)
McCuskey, R. S.: A dynamic and static study of hepatic arterioles and hepatic sphincters. Amer. J. Anat.119, 455–477 (1966)
Merrill, S. L., Chvojka, V. E., Berkowitz, G. M., Texter, E. C.: The effects of glucagon on the superior mesenteric vascular bed. Fed. Proc.21, 200 (1962)
Parmley, W. W., Matloff, J. M., Sonnenblick, E. H.: Hemodynamic effects of glucagon in patients following prothetic valve replacement. Circulation39 (Suppl. 1), 163–167 (1969)
Ross, G.: Regional circulatory effects of pancreatic glucagon. Brit. J. Pharmacol.38, 735–742 (1970)
Rowe, G. G.: Systemic and coronary hemodynamic effects of glucagon. Amer. J. Cardiol.25, 670–674 (1970)
Shoemaker, W. C., van Itallie, T. B., Walker, W. F.: Measurement of hepatic glucose output and hepatic blood flow in response to glucagon. Amer. J. Physiol.196, 315–318 (1959)
Steiner, C., Wit, A. L., Damato, A. N.: Effects of glucagon on atrioventricular conduction and ventricular automaticity in dogs. Circulat. Res.24, 167–168 (1969)
Tibbin, S., Kock, N. G., Schenk, W. G.: Dissociation of the hyperglycemic and vascular effects of glucagon. Surgery67, 816–825 (1970)
Vaughn, C., Warner, H. R., Nelson, R. M.: Cardiovascular effects of glucagon following cardiac surgery. Surgery67, 204–211 (1970)